Brolucizumab Antibody is a research-grade biosimilar monoclonal antibody targeting Vascular endothelial growth factor A. Format: scFv-kappa-heavy (humanized host). Reactivity: Human. Supplied as a liquid in 0.01M PBS pH 7.4. Applications: ELISA, Western blot, flow cytometry, functional assays and in vivo research. Endotoxin: < 10 EU/mg. Purity: >95% purity as determined by SDS-PAGE. For research use only.
Vascular endothelial growth factor A, long form (VEGFA) is a ~43 kDa protein. Participates in the induction of key genes involved in the response to hypoxia and in the induction of angiogenesis such as HIF1A. Involved in protecting cells from hypoxia-mediated cell death. VEGFA is the therapeutic target of bevacizumab (Avastin).
Product Name:
Brolucizumab Antibody
SKU:
GXBS00615
Size:
100 µg, 1 mg
Antibody Type:
Monoclonal Antibody
Target:
L-VEGF
Isotype:
scFv-kappa-heavy
Host Species:
Human
Reactivity:
Human
Applications:
ELISA, WB, FCM, Functional assay, Research in vivo
Synonyms:
ESBA-1008, ESBA1008, RTH258, 1531589-13-5
Purity:
>95% as determined by SDS-PAGE.
Endotoxin Level:
< 10 EU/mg
Formulation:
0.01M PBS pH 7.4.
State of Matter:
Liquid
Regulatory Status:
For research use only. Not suitable for clinical or therapeutic use.
Product Preparation:
Protein A/G purified from cell culture supernatant.
Storage and Handling:
Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
